Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents

J. Fang, R. Islam, W. Islam, H. Yin, V. Subr, T. Etrych, K. Ulbrich, H. Maeda,

. 2019 ; 11 (7) : . [pub] 20190716

Language English Country Switzerland

Document type Journal Article

Grant support
29400001, JP25430162, JP16K08217 Japan Society for the Promotion of Science
16-28594A Ministerstvo Vnitra České Republiky
NV16-28594A MZ0 CEP Register

One obstacle to the successful delivery of nanodrugs into solid tumors is the heterogeneity of an enhanced permeability and retention (EPR) effect as a result of occluded or embolized tumor blood vessels. Therefore, the augmentation of the EPR effect is critical for satisfactory anticancer nanomedicine. In this study, we focused on one vascular mediator involved in the EPR effect, carbon monoxide (CO), and utilized two CO generating agents, one is an extrinsic CO donor (SMA/CORM2 micelle) and another is an inducer of endogenous CO generation via heme oxygenase-1 (HO-1) induction that is carried out using pegylated hemin. Both agents generated CO selectively in solid tumors, which resulted in an enhanced EPR effect and a two- to three-folds increased tumor accumulation of nanodrugs. An increase in drug accumulation in the normal tissue did not occur with the treatment of CO generators. In vivo imaging also clearly indicated a more intensified fluorescence of macromolecular nanoprobe in solid tumors when combined with these CO generators. Consequently, the combination of CO generators with anticancer nanodrugs resulted in an increased anticancer effect in the different transplanted solid tumor models. These findings strongly warrant the potential application of these CO generators as EPR enhancers in order to enhance tumor detection and therapy using nanodrugs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035938
003      
CZ-PrNML
005      
20191015123016.0
007      
ta
008      
191007s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics11070343 $2 doi
035    __
$a (PubMed)31315251
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Fang, Jun $u Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan. fangjun@ph.sojo-u.ac.jp.
245    10
$a Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents / $c J. Fang, R. Islam, W. Islam, H. Yin, V. Subr, T. Etrych, K. Ulbrich, H. Maeda,
520    9_
$a One obstacle to the successful delivery of nanodrugs into solid tumors is the heterogeneity of an enhanced permeability and retention (EPR) effect as a result of occluded or embolized tumor blood vessels. Therefore, the augmentation of the EPR effect is critical for satisfactory anticancer nanomedicine. In this study, we focused on one vascular mediator involved in the EPR effect, carbon monoxide (CO), and utilized two CO generating agents, one is an extrinsic CO donor (SMA/CORM2 micelle) and another is an inducer of endogenous CO generation via heme oxygenase-1 (HO-1) induction that is carried out using pegylated hemin. Both agents generated CO selectively in solid tumors, which resulted in an enhanced EPR effect and a two- to three-folds increased tumor accumulation of nanodrugs. An increase in drug accumulation in the normal tissue did not occur with the treatment of CO generators. In vivo imaging also clearly indicated a more intensified fluorescence of macromolecular nanoprobe in solid tumors when combined with these CO generators. Consequently, the combination of CO generators with anticancer nanodrugs resulted in an increased anticancer effect in the different transplanted solid tumor models. These findings strongly warrant the potential application of these CO generators as EPR enhancers in order to enhance tumor detection and therapy using nanodrugs.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Islam, Rayhanul $u Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan.
700    1_
$a Islam, Waliul $u Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan. Biodynamics Research Foundation, Kumamoto 862-0954, Japan.
700    1_
$a Yin, Hongzhuan $u Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan. Department of General Surgery, Sheng Jing Hospital, China Medical University, Shenyang 110011, China.
700    1_
$a Subr, Vladimir $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague 16206, Czech Republic.
700    1_
$a Etrych, Tomas $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague 16206, Czech Republic.
700    1_
$a Ulbrich, Karel $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague 16206, Czech Republic.
700    1_
$a Maeda, Hiroshi $u Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan. maedabdr@sweet.ocn.ne.jp. Biodynamics Research Foundation, Kumamoto 862-0954, Japan. maedabdr@sweet.ocn.ne.jp.
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 11, č. 7 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31315251 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191015123441 $b ABA008
999    __
$a ind $b bmc $g 1452598 $s 1074488
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 11 $c 7 $e 20190716 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
GRA    __
$a 29400001, JP25430162, JP16K08217 $p Japan Society for the Promotion of Science
GRA    __
$a 16-28594A $p Ministerstvo Vnitra České Republiky
GRA    __
$a NV16-28594A $p MZ0
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...